Marshall Wace
CNTB

Marshall Wace’s Connect Biopharma Holdings CNTB Stock Holding History

Marshall Wace’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Sell
66,013
-62,355
-49% -$163K ﹤0.01% 2813
2025
Q4 		$362K Buy
128,368
+70,337
+121% +$150K ﹤0.01% 2381
2025
Q3 		$85.9K Buy
+58,031
New +$103K ﹤0.01% 2674
2022
Q1 		– Sell
-123,109
Closed -$634K – 3428
2021
Q4 		$634K Buy
+123,109
New +$1.37M ﹤0.01% 2681

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Marshall Wace's CNTB Position: Q1 2026 in Review

Marshall Wace reduced its Connect Biopharma Holdings (CNTB) stake by 49% in Q1 2026, selling an estimated $163K and leaving 66,013 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

Marshall Wace first reported a position in CNTB in Q4 2021 and has held it in 4 quarters since. The position peaked at $634K in Q4 2021. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Marshall Wace held 66,013 shares of Connect Biopharma Holdings worth $173K as of Q1 2026.
  • Marshall Wace sold 62,355 Connect Biopharma Holdings shares in Q1 2026, an estimated $163K.
  • Connect Biopharma Holdings made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2813 holding.
  • Marshall Wace first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 4 quarters since.
  • Marshall Wace's Connect Biopharma Holdings position peaked at $634K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.